LAWYER PROFILE

Simon Amies

UK 2026

Cooley LLP

Ranked in 1 practice area

Life Sciences: Transactional

UK-wide

1 year ranked

About

Provided by Cooley LLP

Practice Areas

Simon is a partner in Cooley’s life sciences practice advising on mergers & acquisitions (public and private), initial public offerings and other capital-raising transactions, and venture and growth capital investments. Simon has extensive experience in advising companies at all stages of their development, as well as counseling investors and investment banks. He has represented a wide range of clients in the life sciences, technology and sustainable technology industries.

Simon’s representative experience includes advising:

* Oxford Biomedica PLC (LSE) on its £60 million placing of ordinary shares

* Medicxi and other investors in the sale of Vicebio to Sanofi for up to $1.6 billion

* EsoBiotec SA on its sale to AstraZeneca for up to $1 billion

* Araris Biotech on its sale to Taiho Pharmaceutical for up to $1.14 billion

* Kheiron Medical Technologies Limited on its sale to DeepHealth

Chambers Review

Provided by Chambers

Chambers Guide to the Legal Profession

Life Sciences: Transactional - UK-wide

Band 3

Individual Editorial

Simon Amies is recommended for his stewardship of high-value, cross-border mergers, acquisitions and financings. His clients include leading innovators in pharma, biotech and health tech.

Learn more about this team View ranking table

Strengths

Provided by Chambers

Simon is very calm, commercial and savvy.
Life Sciences: TransactionalChambers Guide to the Legal Profession
Simon continually displays a deep understanding of our legal needs and business constraints. He is personable, reliable and knowledgeable.
Life Sciences: TransactionalChambers Guide to the Legal Profession